| 产品名称: | Gliocladium viride Matruchot, anamorph |
|---|---|
| 商品货号: | TS210521 |
| Deposited As: | Gliocladium deliquescens Sopp, anamorph |
| Strain Designations: | 457 CBS 228.48, DSM 3704 IMI 40023, LSHB BB283, NRRL 1086 |
| Application: | produces gliodeliquescin A produces levodopa 3,4-dihydroxy-L-phenylalanine, L-dopa production of L-dopa by conversion |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Type Strain: | no |
| Intended Use: | |
| Preceptrol®: | no |
| Medium: | ATCC® Medium 336: Potato dextrose agar (PDA) |
| Growth Conditions: | Temperature: 24.0°C |
| Name of Depositor: | C Thom |
| Isolation: | soil, Washington, DC |
| References: | Rosazza J, et al. Microbiological synthesis of L-dopa. J. Pharm. Sci. 63: 544-547, 1974. PubMed: 4828702 Bruckner H, Przybylski M. Methods for the rapid detection, isolation, and sequence determination of ``peptaibols\ and other Aib-containing peptides of fungal origin. I. Gliodeliquescin A from Gliocladium deliquescens. Chromatographia 19: 188-199, 1984. |